Farma-Derma has a broad commercial portfolio of medical devices and nutraceuticals. Clinical results cited include studies supporting the efficacy of their Cicatridina Ovuli Vaginali with hyaluronic acid for post-surgical recovery in gynaecological procedures. Most products are CE-marked medical devices or food supplements with demonstrated safety profiles.
Therapeutic areas
Men's HealthPulmonologyDermatologyGastroenterologyWomen's Health
Modalities
Medical device (various forms such as ovules, sprays)Food supplement (oral solutions, tablets)Cosmetic product (creams, ointments)Small molecule (in food supplements and medical devices; e.g., hyaluronic acid-based products)Biologic (some products contain biologically derived ingredients like hyaluronic acid)
Industry
Therapeutic Medical Devices
02
Drug pipeline
2 assets
Ginexid
Commercial
Indications
Gynecological conditions
1 more asset in the full pipeline.
03
Partnerships
Merged/partnered with Specchiasol to form leading Italian nutraceutical group.Collaborations with Italian university centers for R&D.
Beyond the preview
Go deeper on Farma-Derma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
Trial phase
Status
Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
Partners
Deal terms
Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
Funding rounds
Investors
Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
Peer companies
Targets
Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
Platforms
Patents
Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
Company news
Sources
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Farma-Derma.